David Bloom treats and ensures follow-up for patients who suffer from schizophrenia and bipolar disorder.

Jean Caron's research relates mainly to the epidemiology of mental illnesses and suicide.

Work from Rémi Quirion's lab has helped to characterize the roles of cholinergic synapses in Alzheimer Disease, neuropeptide Y in depression and learning, and calcitonin gene-related peptide (CGRP) in pain and opioid tolerance.

We all know that, as a population, we are getting older: By 2016, 17% of Canadians will be at least 65 years old and, as the population ages, the number of Alzheimer’s cases will rise accordingly (Statistics Canada) The risk of depression among caregivers of Alzheimer’s sufferers is twice as high as for informal caregivers of individuals with no dementia The needs of our aging population will be a heavy load to bear if we do not find more effective means to treat and prevent ...

The researchers exploring the “Schizophrenia and neurodevelopmental disorders” theme focus on the causes, course, treatment and prevention of: Schizophrenia and other psychotic disorders Attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder and Gilles de la Tourette syndrome Autism (research and evaluation) In Canada, one in a hundred people will be diagnosed with schizophrenia while 3 to 5% of children have an attention deficit...

The researchers working on the “Services, policy and population health” theme come from a wide variety of disciplinary backgrounds: psychiatry, epidemiology, law, anthropology, economy, psychology, social work, administration. Their goal is to inspire and influence developments in mental health policy so that people living with a mental illness can obtain the care and services to which they are entitled. To accomplish this, the researchers: Study the organization of mental health s...

How Blue Is Blue? A 2009 lecture by Camillo Zacchia on depression and burnout - Part 1

Michelle Blanc, a specialist in Web marketing, talks about her struggle with mental illness and the support her blog gave her.

A vaccine-based approach could be an effective therapy for people with mild or moderate form of Alzheimer's disease.

Joseph Rochford, PhD, gives a preview of the 2009 Mini-Psych School.